Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2009, for Zaxis International Inc. (Note: The request metadata listed "Quantum X Labs Inc.", but the filing text identifies the registrant as Zaxis International Inc.). The company is a shell entity with no present operations, having ceased its former biotechnology business in 2002 and emerged from bankruptcy in 2004. Its current plan of operation is to pursue a business combination or acquisition. As of March 31, 2009, the company had 1,073,126 shares of common stock outstanding.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(13,759) | $(11,527) |
| Loss Per Share (Basic/Diluted) | $(0.01) | $(0.01) |
| Cash and Cash Equivalents (End of Period) | $729 | $143 |
| Total Assets | $729 | $117 |
| Total Current Liabilities | $103,855 | $91,655 |
| Stockholders' Deficiency | $(103,126) | $(91,538) |
Liquidity and Debt: The company has no debt in the traditional sense but holds significant current liabilities consisting of accounts payable ($4,500) and advances/accruals due to related parties ($99,355). Cash flow from operations was negative ($88), while financing activities provided $700 in advances from related parties.
Material Changes vs. Prior Period
- Net Loss Increase: Net loss increased by approximately 19% year-over-year, driven by a rise in general and administrative expenses from $11,527 to $13,759.
- Liability Growth: Total current liabilities increased by $12,200, primarily due to an increase in advances from related parties.
- Cash Position: Cash on hand increased from $117 at the end of 2008 to $729 at the end of Q1 2009, funded entirely by related party advances.
- Non-Cash Expenses: The company recorded $9,000 in fair value of services provided by related parties and $2,171 in expenses paid by the issuance of common stock.
Outlook, Risks, and Management Commentary
Management Commentary: Management believes current market uncertainty creates opportunities for acquisitions. The company intends to use its public status to identify and effect a business combination, potentially with financially unstable or early-stage companies. No specific target industry or business has been identified.
Risks and Contingencies:
- Lack of Operations: The company has no revenue and relies entirely on related party funding to sustain operations.
- Liquidity Risk: The company has limited resources and may be unable to raise necessary capital to complete a business combination.
- Dilution: Future business combinations may require the issuance of a substantial number of restricted shares, causing significant dilution to existing shareholders.
- Single Business Dependency: It is probable the company will effect only a single business combination, leaving it undiversified and dependent on the success of that single entity.
Investor Verification Checklist
- Verify the identity of the registrant (Zaxis International Inc.) versus the metadata provided (Quantum X Labs Inc.).
- Confirm the sustainability of operations given the $103,855 in liabilities against only $729 in assets.
- Assess the terms and repayment status of the $99,355 in advances from related parties.
- Monitor for any announcements regarding a specific target for a business combination, as none is currently identified.
- Review the potential for significant dilution if the company issues equity to fund a future acquisition.